NCT00001452View on ClinicalTrials.gov

Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex

CompletedOBSERVATIONAL

Enrollment

1,387

Participants

Timeline

Start Date

December 14, 1995

Conditions

Cushing's SyndromePituitary AdenomaCarney ComplexPrimary Pigmented Nodular Adrenocortical DiseasePeutz-Jeghers Syndrome

Interventions

DRUG

oCRH

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00001452 - Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex | Biotech Hunter | Biotech Hunter